Home

The Korea Herald

Latest news

Most Popular

  1. 1

    Actor Jung Woo-sung admits to being father of model Moon Ga-bi’s child

    Actor Jung Woo-sung admits to being father of model Moon Ga-bi’s child
  2. 2

    Wealthy parents ditch Korean passports to get kids into international school

    Wealthy parents ditch Korean passports to get kids into international school
  3. 3

    First snow to fall in Seoul on Wednesday

    First snow to fall in Seoul on Wednesday
  4. 4

    Man convicted after binge eating to avoid military service

    Man convicted after binge eating to avoid military service
  5. 5

    Final push to forge UN treaty on plastic pollution set to begin in Busan

    Final push to forge UN treaty on plastic pollution set to begin in Busan
  1. 6

    Korea to hold own memorial for forced labor victims, boycotting Japan’s

    Korea to hold own memorial for forced labor victims, boycotting Japan’s
  2. 7

    S. Korea not to attend Sado mine memorial: foreign ministry

    S. Korea not to attend Sado mine memorial: foreign ministry
  3. 8

    Nvidia CEO signals Samsung’s imminent shipment of AI chips

    Nvidia CEO signals Samsung’s imminent shipment of AI chips
  4. 9

    Toxins at 622 times legal limit found in kids' clothes from Chinese platforms

    Toxins at 622 times legal limit found in kids' clothes from Chinese platforms
  5. 10

    Job creation lowest on record among under-30s

    Job creation lowest on record among under-30s
소아쌤

S. Korean disease institute, Moderna agree to collaborate in SFTS mRNA vaccine development

By Yonhap

Published : July 20, 2022 - 11:54

    • Link copied

This photo provided by the National Institute of Infectious Diseases (NIID) on Wednesday, shows (from L to R) NIID head Jang Hee-chang, National Institute of Health chief Kwon Jun-wook and Paul Burton, chief medical officer of Moderna Inc., at a signing ceremony for vaccine collaboration agreement held at the Korea Disease Control and Prevention Agency in Sejong, central South Korea. (NIID) This photo provided by the National Institute of Infectious Diseases (NIID) on Wednesday, shows (from L to R) NIID head Jang Hee-chang, National Institute of Health chief Kwon Jun-wook and Paul Burton, chief medical officer of Moderna Inc., at a signing ceremony for vaccine collaboration agreement held at the Korea Disease Control and Prevention Agency in Sejong, central South Korea. (NIID)

South Korea's state-run National Institute of Infectious Diseases (NIID) said Wednesday it has reached an agreement with Moderna Inc., a US biotech company, to cooperate in the development of a messenger RNA (mRNA) vaccine candidate for severe fever and thrombocytopenia syndrome (SFTS).

The institute said the deal, signed Monday, was its first joint project agreement with an overseas pharmaceutical company. The institute said it expects the research to help elevate the center's research capacity.

Caused by viral infections, SFTS has a high fatality rate, but there is no preventive vaccine or therapeutic agent as of now.

Paul Burton, Moderna's chief medical officer, said the company plans to develop 15 vaccines by 2025, including infectious diseases that threaten global health but still remain largely unnoticed by the public.

Burton said the collaboration with the NIID was significant for serving as an important part of delivering on Moderna's promise of developing new vaccines. (Yonhap)

More from Headlines